The article discusses the current status of DexCom, Inc. in the diabetes stocks market amidst the rising prevalence of diabetes globally. DexCom, known for its continuous glucose monitoring devices, faced challenges due to lower-than-expected revenue projections, leading to a significant drop in its stock price.